Cumberland Pharmaceuticals Inc. Payments to Acquire Marketable Securities
Cumberland Pharmaceuticals Inc. (CPIX) reported Payments to Acquire Marketable Securities of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2022-03-11
- Cumberland Pharmaceuticals Inc. payments to acquire marketable securities for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. payments to acquire marketable securities for the quarter ending 2020-09-30 was $0.00.
- Cumberland Pharmaceuticals Inc. payments to acquire marketable securities for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. payments to acquire marketable securities for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. payments to acquire marketable securities for fiscal 2021 was $0.00.
- Cumberland Pharmaceuticals Inc. payments to acquire marketable securities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Cumberland Pharmaceuticals Inc. payments to acquire marketable securities for fiscal 2019 was $11.75M, a 39.99% decline from fiscal 2018.
- Cumberland Pharmaceuticals Inc. payments to acquire marketable securities for fiscal 2018 was $19.57M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-11 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $0.00 derived: sum of 3 quarters · filed 2022-03-11 | $0.00 10-K · filed 2022-03-11 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | $2.12M derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | $2.12M derived: sum of 3 quarters · filed 2022-03-11 | $2.12M derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-22 | $2.12M derived: sum of 2 quarters · filed 2022-03-11 | $2.12M derived: sum of 3 quarters · filed 2022-03-11 | $3.93M derived: sum of 4 quarters · filed 2022-03-11 | |
| 2019-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.12M derived: sum of 2 quarters · filed 2022-03-11 | $3.93M derived: sum of 3 quarters · filed 2022-03-11 | $11.75M 10-K · filed 2022-03-11 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.81M derived: sum of 2 quarters · filed 2020-11-13 | $9.63M 10-Q · filed 2020-11-13 | $8.35M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $9.63M 10-Q · filed 2020-08-14 | $8.35M derived: sum of 3 quarters · filed 2021-03-12 | $12.28M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-03-31 | $7.82M 10-Q · filed 2020-05-22 | $6.54M derived: sum of 2 quarters · filed 2021-03-12 | $10.47M derived: sum of 3 quarters · filed 2021-03-12 | $12.24M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2018-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.66M derived: sum of 2 quarters · filed 2021-03-12 | $4.42M derived: sum of 3 quarters · filed 2021-03-12 | $19.57M 10-K · filed 2021-03-12 | $20.11M 10-K · filed 2019-03-12 |
| 2018-09-30 | $3.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $5.70M derived: sum of 2 quarters · filed 2019-11-13 | $20.85M 10-Q · filed 2019-11-13 | $21.20M derived: sum of 4 quarters · filed 2020-12-10 | |
| 2018-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $16.92M 10-Q · filed 2019-08-14 | $17.27M derived: sum of 3 quarters · filed 2020-12-10 | $18.09M derived: sum of 4 quarters · filed 2020-12-10 | |
| 2018-03-31 | $15.15M 10-Q · filed 2019-05-15 | $15.50M derived: sum of 2 quarters · filed 2020-12-10 | $16.33M derived: sum of 3 quarters · filed 2020-12-10 | $16.74M derived: sum of 4 quarters · filed 2020-12-10 | |
| 2017-12-31 | $350.00K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | $1.18M derived: sum of 2 quarters · filed 2020-12-10 | $1.59M derived: sum of 3 quarters · filed 2020-12-10 | $2.38M 8-K · filed 2020-12-10 | |
| 2017-09-30 | $827.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.24M derived: sum of 2 quarters · filed 2018-11-14 | $2.03M 10-Q · filed 2018-11-14 | $3.86M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-06-30 | $409.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.20M 10-Q · filed 2018-08-14 | $3.03M derived: sum of 3 quarters · filed 2019-03-12 | $3.72M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-03-31 | $792.72K 10-Q · filed 2018-05-09 | $2.62M derived: sum of 2 quarters · filed 2019-03-12 | $3.31M derived: sum of 3 quarters · filed 2019-03-12 | $5.10M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2016-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $2.51M derived: sum of 2 quarters · filed 2019-03-12 | $4.31M derived: sum of 3 quarters · filed 2019-03-12 | $5.47M 10-K · filed 2019-03-12 | |
| 2016-09-30 | $684.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $2.48M derived: sum of 2 quarters · filed 2017-11-08 | $3.64M 10-Q · filed 2017-11-08 | $5.97M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.96M 10-Q · filed 2017-08-09 | $5.29M derived: sum of 3 quarters · filed 2018-03-09 | $6.44M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-03-31 | $1.17M 10-Q · filed 2017-05-15 | $3.49M derived: sum of 2 quarters · filed 2018-03-09 | $4.65M derived: sum of 3 quarters · filed 2018-03-09 | $7.19M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2015-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $3.48M derived: sum of 2 quarters · filed 2018-03-09 | $6.03M derived: sum of 3 quarters · filed 2018-03-09 | $7.53M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $3.70M derived: sum of 2 quarters · filed 2016-11-03 | $5.20M 10-Q · filed 2016-11-03 | $5.65M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-06-30 | $2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $4.05M 10-Q · filed 2016-08-05 | $4.50M derived: sum of 3 quarters · filed 2017-03-13 | $5.00M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-03-31 | $1.50M 10-Q · filed 2016-05-13 | $1.95M derived: sum of 2 quarters · filed 2017-03-13 | $2.45M derived: sum of 3 quarters · filed 2017-03-13 | $4.96M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2014-12-31 | $452.36K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $952.36K derived: sum of 2 quarters · filed 2017-03-13 | $3.46M derived: sum of 3 quarters · filed 2017-03-13 | $4.21M 10-K · filed 2017-03-13 | |
| 2014-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $3.00M derived: sum of 2 quarters · filed 2015-11-06 | $3.75M 10-Q · filed 2015-11-06 | $3.75M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $3.25M 10-Q · filed 2015-08-07 | $3.25M derived: sum of 3 quarters · filed 2016-03-14 | $3.25M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-03-31 | $750.00K 10-Q · filed 2015-05-15 | $750.00K derived: sum of 2 quarters · filed 2016-03-14 | $750.00K derived: sum of 3 quarters · filed 2016-03-14 | $2.15M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | $1.40M derived: sum of 3 quarters · filed 2016-03-14 | $4.37M 10-K · filed 2016-03-14 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.40M derived: sum of 2 quarters · filed 2014-11-07 | $4.37M 10-Q · filed 2014-11-07 | $7.38M derived: sum of 4 quarters · filed 2015-03-09 | |
| 2013-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $4.37M 10-Q · filed 2014-08-08 | $7.38M derived: sum of 3 quarters · filed 2015-03-09 | $7.88M derived: sum of 4 quarters · filed 2015-03-09 | |
| 2013-03-31 | $2.97M 10-Q · filed 2014-05-12 | $5.98M derived: sum of 2 quarters · filed 2015-03-09 | $6.47M derived: sum of 3 quarters · filed 2015-03-09 | $8.84M derived: sum of 4 quarters · filed 2015-03-09 | |
| 2012-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $3.50M derived: sum of 2 quarters · filed 2015-03-09 | $5.87M derived: sum of 3 quarters · filed 2015-03-09 | $21.86M 10-K · filed 2015-03-09 | |
| 2012-09-30 | $493.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $2.86M derived: sum of 2 quarters · filed 2013-11-06 | $18.85M 10-Q · filed 2013-11-06 | ||
| 2012-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $18.36M 10-Q · filed 2013-08-09 | |||
| 2012-03-31 | $15.99M 10-Q · filed 2013-05-08 | ||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-11 | ||||
| 2010-12-31 | $0.00 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |